CCR3 and prostate carcinoma: We first verified that prostate cancer cells do not secrete this chemokine (Supplementary Fig. 7a) and that the inhibition of CCR3/CCL7 did not affect cell migration in response to 10% FCS (Supplementary Fig. 7b).